Clinical trial
A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for…
NCT00272935 · Duramed Research, Industry · Completed
Key facts
| NCT number | NCT00272935 |
|---|---|
| Title | A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes |
| Official title | A Randomized, Multicenter, Double-blind, Placebo-controlled Trial to Demonstrate the Safety and Efficacy of Daily 0.3 mg Synthetic Conjugated Estrogens, A (Cenestin) for the Treatment of Vasomotor Symptoms in Postmenopausal Women |
| Lead sponsor | Duramed Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hot Flashes |
| Intervention type | Drug, Other |
| Interventions | Cenestin 0.3 mg Tablets, Placebo |
| Enrollment | 400 |
| Start date | Dec 1, 2005 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jan 9, 2006 |
| Last update posted | Jul 3, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: